igf-1 semaglutide The GH/IGF-1 axis in ageing and longevity Insulin-Like Growth Factor Signaling in

All PlexusDx medications come from licensed 503A compounding pharmacies and are HSA/FSA eligible, making treatment accessible nationwide

Before prescribing semaglutide, your healthcare provider will conduct a thorough evaluation, which will include discussing your personal and family medical history, current medications, and your previous experiences with weight loss treatments

Data were analysed using FlowJo (v9) software

PlexusDx providers maintain contact with patients throughout treatment, adjust doses based on tolerance and results, and screen for side effects like nausea, injection-site reactions, or gastrointestinal changes